Related Experiment Video

Updated: Jul 16, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

Juvenile metachromatic leukodystrophy: understanding the disease and implications for nursing care

Catherine Barrell1

  • 1Pediatric Blood and Marrow Transplantation department, Morgan Stanley Children's Hospital of New York-Presbyterian/Columbia University, New York, USA. barrellc@yahoo.com

Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|March 3, 2007
PubMed

Insights

Hematopoietic stem cell transplants offer hope for halting juvenile metachromatic leukodystrophy progression. This guide aids nurses in managing unique patient care needs during this complex pediatric stem cell transplant process.

Area of Science:

  • Neuroscience
  • Pediatric Hematology
  • Genetics

Background:

  • Juvenile metachromatic leukodystrophy (MLD) is a rare, progressive neurodegenerative lysosomal storage disease.
  • Hematopoietic stem cell transplantation (HSCT) is an emerging therapeutic strategy for MLD.
  • Nurses often lack specialized experience in pediatric HSCT for rare genetic disorders like MLD.

Observation:

  • This article addresses the critical need for specialized nursing knowledge in MLD care.
  • It details the pathophysiology and natural history of MLD, explaining HSCT's potential to halt disease progression.
  • A case study illustrates the complex care requirements and unique challenges faced by MLD patients undergoing HSCT.

Findings:

  • HSCT can potentially halt or slow the neurodegeneration associated with MLD.
  • MLD patients undergoing HSCT require comprehensive, multidisciplinary nursing support.
  • Key nursing considerations include a thorough systems review, extensive patient and family education, and managing care for families with multiple affected children.

Implications:

  • Enhanced nursing education and specialized training are crucial for optimizing HSCT outcomes in pediatric MLD.
  • Improved understanding of MLD pathophysiology and HSCT protocols can lead to better patient management.
  • Addressing the holistic needs of patients and families is paramount for successful HSCT in rare neurodegenerative diseases.

More Related Videos

Mouse Models of Periventricular Leukomalacia06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...